Dilemmas in the treatment of HIV and Hepatitis C in Canadian prisons.

Slides:

Advertisements

Similar presentations

Turning the tide: Not without prisons! Promoting comprehensive national HIV responses.

Advertisements

Modelling HIV/AIDS in Southern Africa Centre for Actuarial Research (CARe) A Research Unit of the University of Cape Town.

GAP Report 2014 Prisoners People left behind: Prisoners Link with the pdf, Prisoners.

A Call for Action HIV/AIDS & Hepatitis C in Irish Prisons Irish Penal Reform Trust & Merchants Quay Ireland by Rick Lines, MA July 26, 2002.

Supporting community action on AIDS in developing countries MDG’s and the Law: Creating an Enabling Legislative Environment Anton Kerr Head of Policy –

1 On Point: making prison needle and syringe programs work in Canada January 23rd, 2014 Sandra Ka Hon Chu Canadian HIV/AIDS Legal Network.

Harm Reduction in Prisons: Prisoners’ Rights are Human Rights Rick Lines, MA Executive Director, Irish Penal Reform Trust December 11 th 2003.

WHAT IS THE RELATIONSHIP BETWEEN PRISONS AND RATES OF HIV/AIDS?

“Humanitarian Action” The Saint-Petersburg Charitable Foundation for Medical and Social Programs HAF.

Hepatitis C In Alaska’s Department of Corrections

HIV Prevention, treatment and care among people who inject drugs Fabienne Hariga, MD, MPH Senior HIV Adviser, UNODC Vienna.

Wisconsin Department of Health Services

Incorporating HIV and Viral Hepatitis Testing and Referral into Idaho Drug Court Programs Presented by Idaho Advisory Council on HIV and AIDS, Bebe Thompson,

HIV AIDS Section Fabienne Hariga Senior Adviser UNODC HIV AIDS section, Vienna Comprehensive package of interventions for HIV in prison settings AIDS 2012.

Greenview Hepatitis C Fund Deborah Green Home: Cell: /31/2008.

HIV/AIDS in Prison Settings Dr. Monica Beg HIV/AIDS Unit, United Nations Office on Drugs and Crime, Krakow, Poland September 27, 2004.

STIs/HIV/AIDS. ( 2 ) Sexually transmitted infections (STIs) are spread primarily through sexual contact and are among the most common diseases in the.

Population Health and Policy review for Republic of Kazakhstan Madina Takenova Kazakhstan School of Public Health Kazakhstan APACPH conference Early career.

Overview of the State of the HIV Epidemic in Canada Regional Session on USA and Canada XIX International AIDS Conference Howard Njoo MD, MHSc, FRCPC Director-General.

The Silent Epidemic Any pathogen that spreads from one person to another during sexual contact is called a sexually transmitted infection, or STI. More.

Concepts in Infectious Disease Epidemiology: Models & Prediction David Vlahov, Ph. D.

Safer Needle Devices: Protecting Health Care Workers.

HIV/AIDS STI & Viral Hepatitis WHO/Europe HIV/HCV coinfection in Europe Dr Irina Eramova August 4, 2008 XVII International AIDS Conference, Mexico.

Larry Cuellar Adult Viral Hepatitis Prevention Coordinator Texas Department of State Health Services 2010 STREET OUTREACH WORKERS CONFERENCE June 21, 2010.

Harm Reduction.

At the frontier of drug harm reduction Prisoners’ rights to health & safety David McDonald Visiting Fellow National Centre for Epidemiology and Population.

World Hepatitis Day 2013, 29 th July Establishing a framework for better data collection and surveillance of Hepatitis in South Africa N. Prabdial-Sing.

2013 Update Illustrating HIV/AIDS in the United States Virginia.

SEXUALLY TRANSMITTED DISEASES

Inequities in Responding to HIV and Hepatitis C in Atlantic Canada Susan Kirkland PhD, C Marshall MPA, M Dykeman PhD, G Mugford PhD, J MacDonald MN, I.

Theodore M. Hammett, Ph.D. Sofia Kennedy, M.P.H. Drug Abuse and Risky Behaviors: The Evolving Dynamics of HIV/AIDS NIH-Bethesda, MD May 9, 2007 HIV/AIDS.

Washington D.C., USA, July 2012www.aids2012.org Human rights as a key component of harm reduction strategy targeting people using drugs in Morocco.

TB, STDs, HIV, HEPATITIS C and SUBSTANCE ABUSE: A Local Perspective Paula Kriner, MPH Imperial County Public Health Department Management of TB, STDs,

Ester Wina 24 July th IAC, Melbourne, Australia.

Sexually Transmitted Disease Prevention 101 Presented by Lora Lock RN and Tessa Dillon RN Nova Southeastern University.

Harm Reduction International

Global Fund in Estonia Kaja Põlluste, MD, MPH Department of Public Health & Department of Internal Diseases University of Tartu Estonia.

Bloodborne Pathogens BPW Medical Associates. Bloodborne Pathogens Hep B, Hep C, HIV, Malaria Can be transmitted via blood, CSF, synovial fluid, pleural.

My summer volunteer work at Latin America’s busiest and most modern HIV/AIDS Clinic.

MDG 6: Combat HIV/AIDS and other diseases. Where are we…  Regionally, “on track” for MDG-6 (only a few countries are progressing slowly or show no progress)

HIV Prevention, Treatment and Care in Prisons and other Closed Settings Ehab Salah Prisons and HIV Advisor UNODC, Vienna ICASA 2015 Harare, Zimbabwe 2.

19 June 2007 Prison & Health Expert Meeting Paris Drugs and prisons DG SANCO C4 N. GRENIER.

NDPHS Expert Group on HIV/AIDS and Associated Infections Draft problem tree 5 December, 2011 Chair Dr. Ali Arsalo and ITA Ms Outi Karvonen.

The Canadian Correctional Public Health Program Prison Health Expert Group Sixth Meeting Oslo, Norway September 30, 2008.

2015 Mercury : 1392BE15NP Objective measure the awareness and knowledge about the Hepatitis C virus among the Belgian population transmission.

| Web: The findings and conclusions in this report are those of the authors and do not necessarily represent the official.

HIV testing guidance: know, treat, prevent Spotlight: HIV/AIDS European Centre for Disease Prevention and Control Stockholm, 1 December 2010.

HIV Epidemic in Malaysia. HIV BY AGE GROUPS - MALAYSIA.

Clients Served by the Ryan White HIV/AIDS Program, 2014 Overview Released May 2016.

Projected Non-Communicable Diseases Update 20 June 2011 National Health Insurance Policy Brief 19.

Hepatitis A, B, and C Hepatitis A B and C  Be aware of Hepatitis A,B, or C as they are notorious for attacking the Liver, rendering it incapable of.

PREVENTION OF INFECTIOUS DISEASES IN PRISONS Recent Experience from Portugal Henrique Barros Ministério da Saúde.

Hepatitis C Consultation Services (844) | 9AM-5PM ET, M-F nccc.ucsf.edu The Clinician Consultation Center (CCC) provides up-to-date expert clinical.

Dr. Monica Beg, Chief, HIV/AIDS Section, UNODC

Esityksen nimi / Kirsi Liitsola

HIV-1 and STIs Prevalence and Risk Factors among Miners and Female Sex Workers in the Mining Areas of Gejiu, Yunnan, China Ding Guowei, M.D., M.S. National.

General Situation (Overview)

THE HEALTH SECTOR RESPONSE TO THE HIV/AIDS EPIDEMIC

Addressing Drug Use Together Through a Health Based Approach:

Illustrating HIV/AIDS in the United States

Hepatitis C Consultation Services (844) | 9AM-8PM EST, M-F nccc.ucsf.edu The Clinician Consultation Center (CCC) provides up-to-date expert advice.

Viral Hepatitis in Correctional Settings

Access to Services in Prison and Beyond

P-HSJCC Webinar Series: Family Support for Prisoners with Hep C

Towards a Conducive Legal and Structural Environment

Projected Non-Communicable Diseases Update

Robert G. Gish, Nezam H. Afdhal, Douglas T. Dieterich, K

Age-standardized* prevalence and number of cases of diagnosed diabetes among individuals aged 1 year and older, Canada, 1998/99 to 2008/09. *Age-standardized.

Presentation transcript:

Dilemmas in the treatment of HIV and Hepatitis C in Canadian prisons

Prevalence HIV 1.66% of all federal prisoners known HIV positive Provincial rates vary by province % Seroprevalence levels 10 times higher than in the general population.

Hepatitis C estimated 30% of federal inmates are infected with HCV Cross provincial rates unknown but as high as 52% in some institutions HCV prevalence increasing in prisons Gender difference in infection rates HCV transmitted much more easily than HIV

Transmission in Prison -Sharing needles -Tattoos -Sexual contact

Prevention in Prison -Condoms have been readily available since Bleach has been available since 1994 at Federal institutions. -varied availability in provincial facilities -Needle exchange programs -Methadone

Treatment in Prison HIV- HAART -many inmates miss doses -receive incorrect dosing -meds not reordered -lock down -stigma

HCV Decision to treat is complicated Federal vs provincial Acute vs Chronic Stage of disease Cost Side Effects

References Betteridge, G. “Prisoners’ health and human rights in the HIV/AIDS epidemic” HIV/AIDS Policy and Law Review 9(3)(2004): Discussions in the legal responsibilities of prison systems. Betteridge, G. and G. Dias. Hard Time: promoting HIV and Hepatitis C prevention Programming for Prisoners in Canada, Canadian HIV/AIDS Legal Network and PASAN, Joint United Nations Programme on HIV/AIDS. HIV/AIDS in prisons- statement by the Joint United Nations Programme on HIV/AIDS to the United Nations Commission on Human Rights. Webster, P. CMAJ June 12, 2012 vol. 184 no. 9 First published May 7, 2012, doi: /cmaj